An unexpected effect of matching for HLA-A9 in renal transplantation.
The observation of elevated levels of HLA class I molecules in sera of HLA-A9-positive individuals, and their potential role in the regulation of the immune response, motivated us to study the effect of the presence of HLA-A9 in either kidney donor or recipient on graft survival. Analysis of data from unrelated first transplants performed within the Eurotransplant area revealed that in the group of patients who were not treated with cyclosporine (n = 2051), transplants with no HLA-DR mismatches in which donors (D) and recipients (R) shared the HLA-A9 antigen (D+R+), had significantly poorer graft survival (P = 0.0001) than all other combinations, reaching a 20% difference at 5 years posttransplantation. This effect, which was not found in the CsA-treated patient group (n = 7297), was specific for HLA-A9. The implications of this findings are discussed in relation to the mechanisms of the alloimmune response.
Department of Medical Statistics, University of Leiden, The Netherlands.
C M
CM
Dobbe
J
J
Thorogood
P
P
de Lange
J
J
D'Amaro
G G
GG
Persijn
M J
MJ
Giphart
D003524:Cyclosporins / Q000494:pharmacology; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology; D015234:HLA-A Antigens / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D015337:Multicenter Studies as Topic; D015999:Multivariate Analysis
D003524:Cyclosporins; D015234:HLA-A Antigens; C037709:HLA-A9 antigen; D015395:Histocompatibility Antigens Class I